Revenue: The sum of all revenue fields included for a company's operating activities.
Enzon Pharmaceuticals Inc. (ENZN) Revenue data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-1.05M |
|
-- |
|
-- |
|
$1.00M |
|
$-1.00M |
|
$0.50M |
|
$-0.51M |
|
$-0.51M |
|
$-0.52M |
|
$-0.52M |
|
$-0.52M |
|
$-0.52M |
|
$-1.00M |
|
$-1.00M |
|
74.22M |
|
74.22M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$45.52M |
|
-- |
|
-- |
|
$45.52M |
|
$0.55M |
|
-- |
|
-- |
|
$0.55M |
|
$1.95M |
|
$44.97M |
|
$44.97M |
|
74.21M |
|
| Cash Flow Statement Financials | |
$-0.62M |
|
-- |
|
$-1.27M |
|
$46.86M |
|
$44.97M |
|
$-1.89M |
|
-- |
|
-- |
|
$-1.27M |
|
| Fundamental Metrics & Ratios | |
82.17 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.62M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-26.83% |
|
-1.17% |
|
-1.15% |
|
-1.17% |
|
$0.61 |
|
$-0.01 |
|
$-0.01 |
|